Hazlehurst, Jonathan M.

Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study

Armstrong, M. J., Gaunt, P., Aithal, G. P., Barton, D., Hull, D., Parker, R., Hazlehurst, J. M., Guo, K., Abouda, G., Aldersley, M. A., et al. (2016) · The Lancet

Liver Disease Diagnosis and TreatmentDiabetes Treatment and Management

Cited by 2,203

Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis

Armstrong, M. J., Hull, D., Guo, K., Barton, D., Hazlehurst, J. M., Gathercole, L. L., Nasiri, M., Yu, J., Gough, S. C., Newsome, P. N., et al. (2016) · Journal of Hepatology

Liver Disease Diagnosis and TreatmentDiabetes Treatment and Management

Cited by 456

Glucocorticoids Fail to Cause Insulin Resistance in Human Subcutaneous Adipose Tissue In Vivo

Hazlehurst, J. M., Gathercole, L. L., Nasiri, M., Armstrong, M. J., Borrows, S., Yu, J., Wagenmakers, A. J. M., Stewart, P. M., & Tomlinson, J. W. (2013) · The Journal of Clinical Endocrinology & Metabolism

Adipokines, Inflammation, and Metabolic DiseasesAdipose Tissue and Metabolism

Cited by 66

How to manage weight loss in women with obesity and PCOS seeking fertility?

Hazlehurst, J. M., Singh, P., Bhogal, G., Broughton, S., & Tahrani, A. A. (2022) · Clinical Endocrinology

Ovarian function and disordersReproductive Health and Technologies

Cited by 37

Variation in the commissioning of specialist weight management services and bariatric surgery across England: Results of a freedom of information‐based mapping exercise across the 42 integrated Care Systems of England

Elhariry, M., Iyer, P., Isack, N., Sousa, B., Singh, P., Abbott, S., Wiggins, T., Nirantharakumar, K., Bellary, S., Flint, S. W., et al. (2025) · Clinical Obesity

Bariatric Surgery and OutcomesObesity and Health Practices

Cited by 8